AHRQ: Supplemental Evidence and Data Request on Postpartum Home Blood Pressure Monitoring, Postpartum Treatment of Hypertensive Disorders of Pregnancy, and Peripartum Magnesium Sulfate Regimens for Preeclampsia With Severe Features

The Agency for Healthcare Research and Quality (AHRQ) is seeking scientific information submissions to inform its review on Postpartum Home Blood Pressure Monitoring, Postpartum Treatment of Hypertensive Disorders of Pregnancy, and Peripartum Magnesium Sulfate Regimens for Preeclampsia With Severe Features, including those that describe adverse events. Includes background information and key questions related to the review, as well as a list of potential effect modifiers and subgroups of interest. Submissions are due by April 28, 2022.
Source: Federal Register updates via the Rural Assistance Center - Category: Rural Health Source Type: news